The patent for the proton pump inhibitor (PPI) lansoprazole expired recently and several generic version are now available. In response to this the Drug Tariff has been updated to reflect a lower price for this drug.
It has been added to Category M of the tariff and this has dramatically reduced the price. 28 capsules of the 15mg and 30mg strength cost £4.57 and £6.73 respectively.
Some patients may have been changed from lansoprazole to omeprazole before this price reduction. A rapid change back to lansoprazole may cause confusion and should be undertaken with caution.
Action: This price change now places lansoprazole as the PPI of choice. Care should be taken switching back to lansoprazole therapy in patients who have recently undergone a change.
|« NICE Influenza guidance deactivated||MeReC Extra covers Statins »|